The size of the EPS beat depends on the estimations used. Yahoo quoting Zacks expectation of $2.03 is far from that of LSEG data expected EPS of $2.07.
Either way, I am happy with inline revenue and increased gross margins despite the GLP-1 backdrop.
Ann: ResMed Announces Results for the Fourth Quarter of FY2024, page-6
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$35.21 |
Change
1.630(4.85%) |
Mkt cap ! $22.68B | |||
| Open | High | Low | Value | Volume |
| $35.51 | $35.57 | $34.97 | $44.14M | 1.250M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 597 | $35.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $35.21 | 284 | 1 |
View Market Depth
| Last trade - 10.58am 28/08/2024 (20 minute delay) ? |
| RMD (ASX) Chart |